Iezoside – A New and Potent SERCA inhibitor

Please copy the URL and add it into your RSS Feed Reader.

Facebook X Linkedin Weibo

Download PDF

Synfacts 2022; 18(09): 1028
DOI: 10.1055/s-0041-1738562

Innovative Drug Discovery and Development

Contributor(s):

Dirk Trauner

,

Klaus-Peter Ruehmann

Evans aldol reaction - Babler–Dauben–Michno oxidative transposition - Schmidt glycosylation - SERCA inhibitors

Article published online:
18 August 2022

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany